Skip to main content
. 2021 Nov 8;17(6):1447–1547. doi: 10.5114/aoms/141941

Table XXXV.

Agents used in treatment of lipid disorders in children and adolescents available in Poland

Agent name(s) Doses initial maximum Possible adverse effects Contraindications in children
Statins:
Simvastatin
Atorvastatin
Rosuvastatin
Pravastatin
5–40 mg
5–40 mg
5–20 mg
5–20 mg before 13 years of age
40 mg before 18 years of age
Elevated hepatic aminotransferases, myalgia, myopathy, rhabdomyolysis (very rare), gastrointestinal disorders, fatigue, insomnia, headache, skin lesions, peripheral neuropathy, lupus-like syndrome Drug hypersensitivity, myopathy due to statin administration, active liver disease, high activity of aminotransferases or 3 times the upper limit of normal range during statin administration, renal failure, severe infections, serious trauma and surgery, severe metabolic disorders, hormonal, uncontrolled epileptic seizures
Inhibitor of cholesterol absorption:
Ezetimibe
10 mg Myalgia, myopathy, fatigue, headache, abdominal pain, diarrhoea, flatulence, dyspepsia, gastroesophageal reflux disease, nausea, elevated aminotransferase activity Drug hypersensitivity, impaired hepatic function, high aminotransferase activity